...itsagas
...Ace and i are refering to another drug Mipomersen owned by ISIS...
...ATL1103 is IMO at least 3 years from final phase 3 clinical trials...
..IMO a good estimate given these types of antisence drugs timeline is for 2 and half years per phase trial...
...so once the phase 1 trial is complted by end year, then you are looking approx 5 more years before both phase 2 and 3 are comlete, at the earliest i would say 4 years...
...Its years away from any possible cashflow but DYOR...
...RB
...itsagas...Ace and i are refering to another drug Mipomersen...
-
- There are more pages in this discussion • 25 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
